PHA Classroom banner

PHA Classroom has moved! Visit

>> Back to Recordings

PIM-1: A New Hope for the Diagnosis and Treatment of PH

March 25, 2011

As research in pulmonary hypertension grows, we may find more ways to diagnosis, treat and ultimately cure the disease. Recently, Dr. Sebastien Bonnet of Laval University in Quebec, Canada, made the exciting discovery of the PIM-1 protein; a protein virtually unseen in normal patients, but seen in patients with pulmonary hypertension in amounts relative to the severity of the disease. With positive implications both for early diagnosis and treatment, the discovery of PIM-1 provides more insight into the disease. In this webinar, Dr. Sebastien Bonnet discusses his research and the relationship between PIM-1 and pulmonary hypertension.

Additional Reading:

Note: The full text of these articles requires a subscription to the publication. These links provide the abstract of each article.

Watch Event Recording

If the below recording does not begin automatically, click the arrow. Click Fullscreen button Full screen icon in interface below to watch recording in your full screen. To view the controls, move your mouse anywhere over the video then move to the control interface at the bottom of the video. Please note, you will not need an access code; those directions, if mentioned, are for live event participants. 


Presenter Information

Jessica McKearin, PHA's Associate Director of Special Events

Sébastien Bonnet, PhD
Laval University in Quebec, Canada

Sébastien Bonnet, PhD, is an associate professor with tenure in the faculty of medicine at Laval University in Quebec, Canada. He obtained is PhD in France and received post doctoral training in Milwaukee, Wisconsin and Edmonton, Canada. He is the recipient of numerous international awards including the American Heart Association New Investigator Award (Cournand and Comroe) and the Canadian Cardiovascular Society award. He was elected as the best Canadian researcher in December 2010 for his work on PIM-1 and the molecular origin of PH which was recently published in Circulation and Journal of Experimental medicine. Dr. Bonnet holds a Canadian Research chair position, has published close to 40 publications and is the director of the vascular biology research group in Quebec.As PHA’s Special Events Manager, Jessica works closely with friends and family of PH patients to plan fundraisers across the country. She also creates new special event campaigns, programs and resources, making a variety of special event opportunities available to the PH community.

>>If you liked this recording, you may enjoy PH Treatments: What's on the Horizon

PH Treatments: What's on the Horizon

FacebookTwitterInstagram iconLinkedInYouTube

For optimal viewing of, please use a standards-compliant browser such as Google Chrome or Firefox.

The information provided on the PHA website is provided for general information only. It is not intended as legal, medical or other professional advice, and should not be relied upon as a substitute for consultations with qualified professionals who are familiar with your individual needs.

801 Roeder Road, Ste. 1000, Silver Spring, MD 20910   Patient-to-Patient Support Line: 1-800-748-7274
    Privacy Policy    Provide Feedback & Report Bugs

Designed by Matrix Group International, Inc.® | © 2016 Pulmonary Hypertension Association. All Rights Reserved.


The National Organization for Rare Disorders (NORD) awarded PHA the Abbey S. Meyers Leadership Award in 2012 for outstanding service to PHA members in advocacy, education and other key areas.